Risk factors for mortality in Clostridium difficile infection in the general hospital population: A systematic review

Journal of Hospital Infection

Volumn 82, Issue 1, 2012, Pages 1-12

  Bloomfield, M G ^a,b   Sherwin, J C ^b   Gkrania Klotsas, E ^c  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Clostridium difficile; Mortality; Pseudomembranous colitis; Severity

Indexed keywords

ALBUMIN; CORTICOSTEROID; CREATININE;

ALBUMIN BLOOD LEVEL; CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIARRHEA; FEVER; HEMATOCRIT; HUMAN; KIDNEY DISEASE; LEUKOCYTE COUNT; MORTALITY; NASOGASTRIC TUBE; REVIEW; RISK FACTOR; SEX DIFFERENCE; SYSTEMATIC REVIEW;

CLINICAL LABORATORY TECHNIQUES; CLINICAL MEDICINE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; HOSPITALS, GENERAL; HUMANS; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84865378501     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2012.05.008     Document Type: Review

References (39)

1. Rupnik M., Wilcox M.H., Gerding D.N. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009, 7:526-536.
2. Kelly C.P., LaMont J.T. Clostridium difficile - more difficult than ever. N Engl J Med 2008, 359:1932-1940.
3. Pépin J., Valiquette L., Alary M.-E., et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004, 171:466-472.
4. Kuijper E.J., Coignard B., Tüll P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006, 12(Suppl. 6):2-18.
5. Anonymous Rates of Clostridium difficile infection among hospitalised patients aged ≥65 years, by age group - National Hospital Discharge Survey, United States, 1996-2009. Morb Mortal Wkly Rep 2011, 60:1171.
6. Loo V.G., Poirier L., Miller M.A., et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005, 353:2442-2449.
7. Karas J.A., Enoch D.A., Aliyu S.H. A review of mortality due to Clostridium difficile infection. J Infect 2010, 61:1-8.
8. Zar F.A., Bakkanagari S.R., Moorthi K.M., Davis M.B. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007, 45:302-307.
9. Gerding D.N., Johnson S. Management of Clostridium difficile infection: thinking inside and outside the box. Clin Infect Dis 2010, 51:1306-1313.
10. Fujitani S., George W.L., Murthy A.R. Comparison of clinical severity score indices for Clostridium difficile infection. Infect Control Hosp Epidemiol 2011, 32:220-228.
11. Valiquette L., Pépin J., Do X.V., et al. Prediction of complicated Clostridium difficile infection by pleural effusion and increased wall thickness on computed tomography. Clin Infect Dis 2009, 49:554-560.
12. Umoh N., Sucandy I., Dancea H., Choi L., Esolen L., Olson M. Predictors of fulminant colitis and mortality in patients with Clostridium difficile infection. Dis Colon Rectum 2009, 52:765-766.
13. Pépin J., Valiquette L., Gagnon S., Routhier S., Brazeau I. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027. Am J Gastroenterol 2007, 102:2781-2788.
14. Bauer M.P., Notermans D.W., van Benthem B.H.B., et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011, 377:63-73.
15. Manek K., Williams V., Callery S., Daneman N. Reducing the risk of severe complications among patients with Clostridium difficile infection. Can J Gastroenterol 2011, 25:368-372.
16. Mcgowan A.P., Lalayiannis L.C., Sarma J.B., Marshall B., Martin K.E., Welfare M.R. Thirty-day mortality of Clostridium difficile infection in a UK National Health Service Foundation Trust between 2002 and 2008. J Hosp Infect 2011, 77:11-15.
17. Bhangu A., Czapran A., Bhangu S., Pillay D. Optimum timing of blood tests for monitoring patients with Clostridium difficile-associated diarrhea. J Invest Med 2010, 58:621.
18. Bhangu S., Bhangu A., Nightingale P., Michael A. Mortality and risk stratification in patients with Clostridium difficile-associated diarrhoea. Colorectal Dis 2010, 12:241-246.
19. Cadena J., Thompson G.R., Patterson J.E., et al. Clinical predictors and risk factors for relapsing Clostridium difficile infection. Am J Med Sci 2010, 339:350-355.
20. Das R., Feuerstadt P., Brandt L.J. Glucocorticoids are associated with increased risk of short-term mortality in hospitalized patients with Clostridium difficile-associated disease. Am J Gastroenterol 2010, 105:2040-2049.
21. Dudukgian H., Sie E., Gonzalez-Ruiz C., Etzioni D.A., Kaiser A.M. C. difficile colitis - predictors of fatal outcome. J Gastrointest Surg 2010, 14:315-322.
22. Naggie S., Frederick J., Pien B.C., et al. Community-associated Clostridium difficile infection: experience of a veteran affairs medical center in southeastern USA. Infection 2010, 38:297-300.
23. Pant C., Madonia P., Minocha A., Manas K., Jordan P., Bass P. Laboratory markers as predictors of mortality in patients with Clostridium difficile infection. J Invest Med 2010, 58:43-45.
24. Southern W.N., Rahmani R., Aroniadis O., et al. Postoperative Clostridium difficile-associated diarrhea. Surgery 2010, 148:24-30.
25. Wilson V., Cheek L., Satta G., et al. Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom. Clin Infect Dis 2010, 50:e77-e81.
26. Gravel D., Miller M., Simor A., et al. Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program study. Clin Infect Dis 2009, 48:568-576.
27. Gujja D., Friedenberg F.K. Predictors of serious complications due to Clostridium difficile infection. Aliment Pharmacol Ther 2009, 29:635-642.
28. Henrich T.J., Krakower D., Bitton A., Yokoe D.S. Clinical risk factors for severe Clostridium difficile-associated disease. Emerg Infect Dis 2009, 15:415-422.
29. Hardt C., Berns T., Treder W., Dumoulin F.-L. Univariate and multivariate analysis of risk factors for severe Clostridium difficile-associated diarrhoea: importance of co-morbidity and serum C-reactive protein. World J Gastroenterol 2008, 14:4338-4341.
30. Labbe A.-C., Poirier L., Maccannell D., et al. Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrob Agents Chemother 2008, 52:3180-3187.
31. Andrews C.N., Raboud J., Kassen B.O., Enns R. Clostridium difficile-associated diarrhea: predictors of severity in patients presenting to the emergency department. Can J Gastroenterol 2003, 17:369-373.
32. Morris A.M., Jobe B.A., Stoney M., Sheppard B.C., Deveney C.W., Deveney K.E. Clostridium difficile colitis: an increasingly aggressive iatrogenic disease?. Arch Surg 2002, 137:1096-1100.
33. Dharmarajan T., Sipalay M., Shyamsundar R., Norkus E., Pitchumoni C. Co-morbidity, not age predicts adverse outcome in Clostridium difficile colitis. World J Gastroenterol 2000, 6:198-201.
34. Jobe B.A., Grasley A., Deveney K.E., Deveney C.W., Sheppard B.C. Clostridium difficile colitis: an increasing hospital-acquired illness. Am J Surg 1995, 169:480-483.
35. Prendergast T.M., Marini C.P., D'Angelo A.J., Sher M.E., Cohen J.R. Surgical patients with pseudomembranous colitis: factors affecting prognosis. Surgery 1994, 116:768-774.
36. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
37. Crobach M.J.T., Dekkers O.M., Wilcox M.H., Kuijper E.J. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect 2009, 15:1053-1066.
38. Planche T., Aghaizu A., Holliman R., et al. Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis 2008, 8:777-784.
39. Mlangeni D.A., Harris M.D., Franklin L., Hunt P., Karas J.A., Enoch D.A. Death certificates provide a poor estimation of attributable mortality due to Clostridium difficile when compared to a death review panel using defined criteria. J Hosp Infect 2011, 77:370-371.